Sustained response to pembrolizumab without prior chemotherapy in high-grade serous ovarian carcinoma with CSMD3 mutation
Publication date: Available online 15 June 2020Source: Gynecologic Oncology ReportsAuthor(s): Julie Terzic, Amanda Seipel, Jean Dubuisson, Jean-Christophe Tille, Petros Tsantoulis, Alfredo Addeo, S.Intidhar Labidi-Galy
Source: Gynecologic Oncology Reports - Category: OBGYN Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | OBGYN | Ovarian Cancer | Ovaries | Serous Carcinoma